Original article
Importance of measurable residual disease in the outcome of adults with acute lymphoblastic leukemia after allogeneic stem cell transplantation: Long follow-up analysis from a single transplant center
La importancia de la enfermedad medible residual en los resultados de los adultos con leucemia aguda linfoblástica tras el trasplante alogénico de células progenitoras hematopoyéticas: análisis de una serie con seguimiento prolongado de un único centro trasplantador
Irati Ormazabal Véleza,b,c,
, Arkaitz Galbete Jiménezd, Miriam Sánchez-Escamillae, Ana Marcos-Jiménezf, Elena Fernández-Ruizb,g, Jon Salmanton-Garcíah,i, Arancha Bermúdez Rodrígueze, Ángela Figuera Álvareza,b
Corresponding author
a Hematology Department, Hospital Universitario de La Princesa, Madrid, Spain
b Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain
c Hematology Department, Hospital Universitario de Navarra, Iruña-Pamplona, Spain
d Statitstics, Computing and Mathematics Department, Universidad Pública de Navarra (UPNA), Iruña-Pamplona, Spain
e Hematology Department, Hospital Universitario Marqués de Valdecilla, Spain
f Immunology Department, Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria La Princesa (IIS-Princesa), Madrid, Spain
g Molecular Biology Department, Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria La Princesa (IIS-Princesa), Madrid, Spain
h Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany
i Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology, University of Cologne, Cologne, Germany
Ver más